[07 May 2013]
Products Affected - Description
Isosorbide dinitrate immediate release tablets, Major
5 mg unit dose, 100 count (NDC 00904-2150-61) - discontinued
10 mg unit dose, 100 count (NDC 00904-2151-61) - discontinued
Isosorbide dinitrate immediate release tablets, Sandoz
10 mg unit dose, 100 count (NDC 00781-1556-13)
Isosorbide dinitrate immediate release tablets, West-Ward
2.5 mg sublingual tablets, 100 count (NDC 00143-1765-01)
5 mg, 100 count (NDC 00143-1769-01)
5 mg, 1000 count (NDC 00143-1769-10)
10 mg, 100 count (NDC 00143-1171-01)
10 mg, 1000 count (NDC 00143-1771-10)
20 mg, 100 count (NDC 00143-1772-01)
20 mg, 1000 count (NDC 00143-1772-10)
30 mg, 100 count (NDC 00143-1773-01)
30 mg, 1000 count (NDC 00143-1773-10)
Reason for the Shortage
- Sandoz and West-Ward could not provide a reason for the shortage.
- Major discontinued isosorbide dinitrate 5 mg immediate release tablets in April 2012. Major discontinued isosorbide dinitrate 10 mg immediate release tablets in April 2013.
Available Products
Isosorbide dinitrate immediate release tablets, Major
20 mg unit dose, 100 count (NDC 00904-2154-61)
Isosorbide dinitrate immediate release tablets, Par
30 mg, 100 count (NDC 49884-0009-01)
30 mg, 1000 count (NDC 49884-0009-10)
Isosorbide dinitrate immediate release tablets, Sandoz
5 mg, 100 count (NDC 00781-1635-01)
5 mg, 1000 count (NDC 00781-1635-10)
10 mg, 100 count (NDC 00781-1556-01)
10 mg, 1000 count (NDC 00781-1556-10)
20 mg unit dose, 100 count (NDC 00781-1695-13)
20 mg, 100 count (NDC 00781-1695-01)
20 mg, 1000 count (NDC 00781-1695-10)
Estimated Resupply Dates
- Sandoz has isosorbide dinitrate 10 mg immediate-release, unit-dose tablets on back order with an estimated release date of mid-June 2013.
- West-Ward has all isosorbide dinitrate immediate-release tablets on back order and the company estimates a release date of 2nd quarter 2013.
Related Shortages
Updated
May 7, 2013; April 5, 2013; February 20, 2013; January 18, 2013; December 7, 2012; November 7, 2012; October 19, 2012; September 26, 2012; September 12, 2012; August 21, 2012; July 26, 2012; June 25, 2012; May 24, 2012; April 25, 2012, University of Utah, Drug Information Service. Copyright 2013, Drug Information Service, University of Utah, Salt Lake City, UT.
Disclaimer
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins